Deborah Kuk
Publications by Year
Research Areas
Sarcoma Diagnosis and Treatment, Cancer Immunotherapy and Biomarkers, Immune cells in cancer, Cardiac tumors and thrombi, Immunotherapy and Immune Responses
Most-Cited Works
- → T-cell invigoration to tumour burden ratio associated with anti-PD-1 response(2017)1,620 cited
- → Multi-institutional Validation Study of the American Joint Commission on Cancer (8th Edition) Changes for T and N Staging in Patients With Pancreatic Adenocarcinoma(2016)489 cited
- → Histology-based Classification Predicts Pattern of Recurrence and Improves Risk Stratification in Primary Retroperitoneal Sarcoma(2015)360 cited
- → Integrated NY-ESO-1 antibody and CD8+T-cell responses correlate with clinical benefit in advanced melanoma patients treated with ipilimumab(2011)328 cited
- → The efficacy of anti‐PD‐1 agents in acral and mucosal melanoma(2016)298 cited
- → Prevalence of tumor-infiltrating lymphocytes and PD-L1 expression in the soft tissue sarcoma microenvironment(2014)291 cited
- → An International Multi-Institutional Validation of Age 55 Years as a Cutoff for Risk Stratification in the AJCC/UICC Staging System for Well-Differentiated Thyroid Cancer(2016)225 cited
- → Prognosis of Mucosal, Uveal, Acral, Nonacral Cutaneous, and Unknown Primary Melanoma From the Time of First Metastasis(2016)199 cited
- → Near universal detection of alterations in CTNNB1 and Wnt pathway regulators in desmoid‐type fibromatosis by whole‐exome sequencing and genomic analysis(2015)167 cited
- → Associations Between Mutations and Histologic Patterns of Mucin in Lung Adenocarcinoma(2014)164 cited